# Iteration 2: Security

## Focus
Security posture of the governance/rollout phase. The phase ships read-time documents and a CI-checkable manifest, not code. Assess: does the planned layer introduce any new write path, trust boundary, secret, or exposure? Is the CI-never-auto-commits boundary coherent? Are the security-relevant references (the `legacy_grandfathered` bypass deletion, the prod-mode gate) correctly scoped out to sibling phases?

Files: `spec.md` (NFR-S01, edge cases, INV-1/INV-2), `plan.md` (affected surfaces), `checklist.md` (Security section).

## Scorecard
- Dimensions covered: security
- Files reviewed: 3 (spec.md, plan.md, checklist.md)
- New findings: P0=0 P1=0 P2=0
- Refined findings: P0=0 P1=0 P2=0
- New findings ratio: 0.0

## Findings

_No security findings._

## Cross-Reference Results
| Protocol | Status | Gate | Evidence | Notes |
|----------|--------|------|----------|-------|
| _(traceability protocols run in Iteration 3)_ | n/a | n/a | n/a | Security pass introduces no protocol results |

## Assessment
- New findings ratio: 0.0
- Dimensions addressed: security
- Novelty justification: Clean pass, confirmed by evidence rather than assumed. `spec.md:161` (NFR-S01): "The governance layer adds no new write path and no new trust boundary, it documents the existing boundaries and the CI-never-auto-commits rule." Corroborated by `plan.md:102` ("This phase ships governance documents and a rollout manifest, not code") and the Files-to-Change table (`spec.md:94-101`) whose only Create entries are five `.md` documents; the sole code-surface row (`validate.sh`) is `Reference`, not `Change`. The security-relevant mutations the program will eventually make — deleting the `legacy_grandfathered` bypass and flipping warn→error — are explicitly scoped OUT (`spec.md:90`, `spec.md:101`) and owned by sibling `004-a4-schema-warn-to-error`. INV-1 (`spec.md:81`, no `safe` classification for body-touching fixes) and INV-2 (no retrieval promotion without a prod-at-3 read) are correctly framed as *constraints the governance layer documents*, not new privileges it grants. The CI-never-auto-commits rationale (`spec.md:125` / `research/research.md:110`: "the governance boundary is not whether a fix is safe but whether its blast radius is human-reviewed") is internally coherent and security-positive. No secrets, no env handling, no parser/path surface introduced by this phase.

## Ruled Out
- "The phase touches validate.sh and could alter validation trust": Ruled out. The validate.sh row is `Reference` only (`spec.md:101`, `plan.md:107`); the bypass deletion is deferred to sibling 004. No rule is registered by this phase (`plan.md:108`).
- "Security-sensitive override applies (minStabilizationPasses=2, closed-finding replay)": Ruled out for this lineage. The override triggers when the run *targets* security/path/env/schema/persistence changes. This phase introduces none — it documents existing boundaries. Standard convergence (minStabilizationPasses=1) applies.

## Dead Ends
- Searching for an introduced trust boundary: none exists to audit; the phase is documentation-only by design.

## Recommended Next Focus
Iteration 3: traceability — execute the core protocols `spec_code` and `checklist_evidence`, and validate the research-seam citations and external file references (the stale `run-eval-v2.mjs` path and the forward-referenced `computeAuthoredDocQuality` symbol found in init recon).

Review verdict: PASS
